Effect of stereochemistry at position C20 on the antiproliferative activity and selectivity of N-acylated derivatives of salinomycin.

Dominika Czerwonka, Szymon Sobczak, Greta Klejborowska, Ewa Maj, Michał Antoszczak, Adam Huczyński, Joanna Wietrzyk, Julia Krzywik, Michał Sulik, Małgorzata Ullrich, Tomasz Sobierajski, Jarosław Sukiennik, Witold Mozga, Przemysław Pilaszek

Journal: European journal of medicinal chemistry 2025;291():117598

PMID: 40199024

Abstract

Salinomycin (SAL), a natural polyether ionophore, exhibits a broad spectrum of pharmacological activities, including potent anticancer activity. Over the past decade, much effort has been put into developing methods for rational chemical modification of SAL to obtain semisynthetic analogs with higher anticancer activity than the native structure. In this paper, we describe an optimized procedure for synthesizing C20-aminosalinomycin 2 with native stereochemistry at position C20, which was confirmed by single-crystal X-ray diffraction analysis. We further transformed amine precursor 2 into a series of 48 C20-N-(thio)acylated products, including N-(sulfon)amides, N-(thio)ureas, and N-carbamates (urethanes), along with their sulfur analogs, i.e., S-substituted thiocarbamates and dithiocarbamates. This previously unreported class of derivatives showed superior cytotoxicity mostly in the nano- and subnanomolar concentration range and improved selectivity toward human cancer cells compared to those of chemically unmodified SAL and a commonly used oncological drug cisplatin. Of note, the obtained products inhibited the proliferation of reference cancer cells more effectively than their C20-epi-N-acylated counterparts, pointing out the pivotal role of stereochemistry at position C20. Our findings support the premise that the modification of SAL is a fruitful strategy for products with promising biological activity profiles. Moreover, the straightforward protocols should be of significant value for more elaborate modifications of SAL in the future.

Copyright © 2025 Elsevier Masson SAS. All rights reserved.

Address: Department of Medical Chemistry, Faculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznańskiego 8, 61‒614, Poznań, Poland.; FiLeClo Ltd., Al. Piłsudskiego 141, 92‒318, Łódź, Poland.; Department of Materials Chemistry, Faculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznańskiego 8, 61‒614, Poznań, Poland.; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53‒114, Wrocław, Poland.; Department of Medical Chemistry, Faculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznańskiego 8, 61‒614, Poznań, Poland. Electronic address: [email protected].

Link outs

Free resources

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.